Upregulated hPuf-A promotes breast cancer tumorigenesis

Tumor Biology

Volumn 34, Issue 5, 2013, Pages 2557-2564

  Fan, Chi Chen ^a   Lee, Liek Yeow ^b   Yu, Ming Ying ^b   Tzen, Chi Yuan ^a   Chou, Chi ^a   Chang, Mau Sun ^b,c  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c INSTITUTE OF BIOLOGICAL CHEMISTRY   (Taiwan)

Author keywords

Breast cancer; DDX3; hPuf A; Puf; RbAp48

Indexed keywords

EID: 84885423249     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-0801-4     Document Type: Article

References (18)

1. Wickens M, Bernstein DS, Kimble J, Parker R. A PUF family portrait: 3′UTR regulation as a way of life. Trends Genet. 2002;18:150-7.
2. Wang X, McLachlan J, Zamore PD, Hall TM. Modular recognition of RNA by a human Pumilio-homology domain. Cell. 2002;110:501-12.
3. Lu G, Dolgner SJ, Hall TM. Understanding and engineering RNA sequence specificity of PUF proteins. Curr Opin Struct Biol. 2009;19:110-5.
4. Zhang B, Gallegos M, Puoti A, Durkin E, Fields S, Kimble J, et al. A conserved RNA binding protein that regulates patterning of sexual fates in the C. elegans hermaphrodite germ line. Nature. 1997;390:477-84.
5. Zamore PD, Williamson JR, Lehmann R. The Pumilio protein binds RNA through a conserved domain that defines a new class of RNA-binding proteins. RNA. 1997;3:1421-33.
6. Miller MA, Olivas WM. Roles of Puf proteins in mRNA degradation and translation. Wiley Interdiscip Rev RNA. 2011;2:471-92.
7. Subramaniam K, Seydoux G. Dedifferentiation of primary spermatocytes into germ cell tumors in C. elegans lacking the Pumilio-like protein PUF-8. Curr Biol. 2003;13:134-9.
8. Kuo MW, Wang SH, Chang JC, Chang CH, Huang LJ, Lin HH, et al. A novel puf-A gene predicted from evolutionary analysis is involved in the development of eyes and primordial germ-cells. PLoS One. 2009;4:e4980.
9. Chang HY, Fan CC, Chu PC, Hong BE, Lee HJ, Chang MS. hPuf-A/KIAA0020 modulates PARP-1 cleavage upon genotoxic stress. Cancer Res. 2011;71:1126-34.
10. Yoder BJ, Wilkinson EJ, Massoll NA. Molecular and morphologic distinctions between infiltrating ductal and lobular carcinoma of the breast. Breast J. 2007;13:172-9.
11. Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, et al. Race, breast cancer subtypes, and survival in the Carolina breast cancer study. Jama. 2006;295:2492-502.
12. Brickner AG, Warren EH, Caldwell JA, Akatsuka Y, Golovina TN, Zarling AL, et al. The immunogenicity of a new human minor histocompatibility antigen results from differential antigen processing. J Exp Med. 2001;193:195-206.
13. Martello G, Rosato A, Ferrari F, Manfrin A, Cordenonsi M, Dupont S, et al. A microRNA targeting dicer for metastasis control. Cell. 2010;141:1195-207.
14. Lacroix M, Leclercq G. Relevance of breast cancer cell lines as models for breast tumours: an update. Breast Cancer Res Treat. 2004;83:249-89.
15. Harvey JM, Clark GM, Osborne CK, Allred DC. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol. 1999;17:1474-81.
16. Rojo F, García-Parra J, Zazo S, Tusquets I, Ferrer-Lozano J, Menendez S, et al. Nuclear PARP-1 protein overexpression is associated with poor overall survival in early breast cancer. Ann Oncol. 2012;23:1156-64.
17. Botlagunta M, Vesuna F, Mironchik Y, Raman A, Lisok A, Winnard Jr P, et al. Oncogenic role of DDX3 in breast cancer biogenesis. Oncogene. 2008;27:3912-22.
18. Scuto A, Zhang H, Zhao H, Rivera M, Yeatman TJ, Jove R, et al. RbAp48 regulates cytoskeletal organization and morphology by increasing K-Ras activity and signaling through mitogen-activated protein kinase. Cancer Res. 2007;67:10317-24.